JP2016530337A5 - - Google Patents

Download PDF

Info

Publication number
JP2016530337A5
JP2016530337A5 JP2016543407A JP2016543407A JP2016530337A5 JP 2016530337 A5 JP2016530337 A5 JP 2016530337A5 JP 2016543407 A JP2016543407 A JP 2016543407A JP 2016543407 A JP2016543407 A JP 2016543407A JP 2016530337 A5 JP2016530337 A5 JP 2016530337A5
Authority
JP
Japan
Prior art keywords
compound
formula
tspo
subject
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016543407A
Other languages
English (en)
Japanese (ja)
Other versions
JP6401791B2 (ja
JP2016530337A (ja
Filing date
Publication date
Priority claimed from GBGB1316762.2A external-priority patent/GB201316762D0/en
Application filed filed Critical
Publication of JP2016530337A publication Critical patent/JP2016530337A/ja
Publication of JP2016530337A5 publication Critical patent/JP2016530337A5/ja
Application granted granted Critical
Publication of JP6401791B2 publication Critical patent/JP6401791B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016543407A 2013-09-20 2014-09-19 インビボイメージングのためのカルバゾール化合物 Active JP6401791B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1316762.2A GB201316762D0 (en) 2013-09-20 2013-09-20 Novel compounds
GB1316762.2 2013-09-20
PCT/EP2014/069969 WO2015040148A1 (en) 2013-09-20 2014-09-19 Carbazole compounds for in vivo imaging

Publications (3)

Publication Number Publication Date
JP2016530337A JP2016530337A (ja) 2016-09-29
JP2016530337A5 true JP2016530337A5 (enExample) 2017-10-19
JP6401791B2 JP6401791B2 (ja) 2018-10-10

Family

ID=49553181

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016543407A Active JP6401791B2 (ja) 2013-09-20 2014-09-19 インビボイメージングのためのカルバゾール化合物

Country Status (6)

Country Link
US (1) US9951011B2 (enExample)
EP (1) EP3046904B1 (enExample)
JP (1) JP6401791B2 (enExample)
CN (2) CN105593210B (enExample)
GB (1) GB201316762D0 (enExample)
WO (1) WO2015040148A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201316762D0 (en) * 2013-09-20 2013-11-06 Ge Healthcare Ltd Novel compounds
CN109776394B (zh) * 2019-03-05 2020-10-27 朱晓琴 一种咔唑衍生物及其制备方法与制备h2s供体的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0905328D0 (en) * 2009-03-27 2009-05-13 Ge Healthcare Ltd Indole derivatives
GB201016038D0 (en) * 2010-09-24 2010-11-10 Ge Healthcare Ltd In vivo imaging method
GB201016411D0 (en) * 2010-09-30 2010-11-10 Ge Healthcare Ltd In vivo imaging method for cancer
GB201316762D0 (en) * 2013-09-20 2013-11-06 Ge Healthcare Ltd Novel compounds

Similar Documents

Publication Publication Date Title
JP2013523621A5 (enExample)
MacDonald et al. Pinhole SPECT of mice using the LumaGEM gamma camera
Qu et al. Quick assembly of 1, 4-diphenyltriazoles as probes targeting β-amyloid aggregates in Alzheimer's disease
JP2012521973A5 (enExample)
JP2018058847A5 (enExample)
JP2017521387A5 (enExample)
EA201100301A1 (ru) Daa-пиридин в качестве лиганда периферического бензодиазепинового рецептора для диагностической визуализации и фармацевтического лечения
JP5592377B2 (ja) 放射能標識のための[18f]sfbの単純化ワンポット合成
Seo et al. Tumor dosimetry using [124I] m-iodobenzylguanidine microPET/CT for [131I] m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model
RU2016112547A (ru) Имидазо[1,2-а]пиридин-7-амины в качестве средств визуализации
Zhang et al. Synthesis, preclinical evaluation, and first-in-human PET study of quinoline-containing PSMA tracers with decreased renal excretion
JP2019527225A5 (enExample)
Estorch et al. Future challenges of multimodality imaging
JP2012504581A5 (enExample)
JP2016530337A5 (enExample)
HRP20201372T1 (hr) Radioaktivno označeni pet mglur2/3 ligandi
JP2013507345A5 (enExample)
JP2018502829A5 (enExample)
WO2015178618A1 (ko) 엑소좀을 방사성 물질로 표지하는 방법 및 그 용도
JP2009538894A5 (enExample)
JP2012520855A5 (enExample)
Lin et al. PET oncological radiopharmaceuticals: current status and perspectives
Cheng et al. Comparison of 18F PET and 99mTc SPECT imaging in phantoms and in tumored mice
JP2012523388A5 (enExample)
Sharma Translational multimodality neuroimaging